Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc T Goodman

Showing results (261-270 of 341) with videos related to

Pageof 35
Sort By:
Journal of the National Cancer Institute|January 23, 2023
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysisZhuxuan Fu, Maria Mori Brooks, Sarah Irvin, et al.
Plos One|September 28, 2011
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancersJonathan Beesley, Hilda A Pickett, Sharon E Johnatty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association ConsortiumCatherine M Phelan, Ya-Yu Tsai, Ellen L Goode, et al.
Cancer Causes & Control : CCC|March 5, 2013
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studiesMette T Faber, Susanne K Kjær, Christian Dehlendorff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Type I and II endometrial cancers: have they different risk factors?Veronica Wendy Setiawan, Hannah P Yang, Malcolm C Pike, et al.
Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2021
Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian CancerMichael C J Quinn, Karen McCue, Wei Shi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2016
Investigation of Exomic Variants Associated with Overall Survival in Ovarian CancerStacey J Winham, Ailith Pirie, Yian Ann Chen, et al.
Pageof 35

Showing results (261-270 of 341) with videos related to

Sort By:
Pageof 35
Journal of the National Cancer Institute|January 23, 2023
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysisZhuxuan Fu, Maria Mori Brooks, Sarah Irvin, et al.
Plos One|September 28, 2011
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancersJonathan Beesley, Hilda A Pickett, Sharon E Johnatty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association ConsortiumCatherine M Phelan, Ya-Yu Tsai, Ellen L Goode, et al.
Cancer Causes & Control : CCC|March 5, 2013
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studiesMette T Faber, Susanne K Kjær, Christian Dehlendorff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Type I and II endometrial cancers: have they different risk factors?Veronica Wendy Setiawan, Hannah P Yang, Malcolm C Pike, et al.
Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2021
Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian CancerMichael C J Quinn, Karen McCue, Wei Shi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2016
Investigation of Exomic Variants Associated with Overall Survival in Ovarian CancerStacey J Winham, Ailith Pirie, Yian Ann Chen, et al.
Pageof 35